Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.

Stefan HagelSandra FiedlerAndreas HohnAlexander BrinkmannOtto R FreyHeike HoyerPeter SchlattmannMichael KiehntopfJason A RobertsMathias W Pletznull null

Published in: Trials (2019)

German Clinical Trials Register (GermanCTR), DRKS00011159 . Registered on 10 October 2016.

Keyphrases

clinical trial
study protocol
acute kidney injury
septic shock
intensive care unit
gram negative
phase ii
randomized controlled trial
open label
double blind
phase iii